Lin BioScience, Inc. (TPEX:6696)
162.00
-2.00 (-1.22%)
Nov 17, 2026, 1:59 PM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 134.33 billion as of November 17, 2026. It is the 4,069th most valuable company in the world and the 103rd biggest in Taiwan. Its market cap has increased by 487.28% in one year.
Market Cap
134.33B
Enterprise Value
132.79B
Revenue
n/a
Global Rank
Country Rank
#103 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 134.33B, an increase of 4,506.52%. That is a compound annual growth rate of 60.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 138.06B | 320.38% |
| Dec 31, 2025 | 32.84B | 203.76% |
| Dec 31, 2024 | 10.81B | 20.85% |
| Dec 29, 2023 | 8.95B | -28.90% |
| Dec 30, 2022 | 12.58B | -1.94% |
| Dec 30, 2021 | 12.83B | 83.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 116.34B |
| Pell Bio-Med Technology | 59.43B |
| Oneness Biotech | 22.18B |
| Steminent Biotherapeutics | 21.07B |
| Sunmax Biotechnology | 20.94B |
| CHO Pharma | 18.19B |
| TaiMed Biologics | 17.40B |
| EirGenix | 15.83B |